StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3052% above fair value
$10.57−0.69 (-6.13%)

Close on Nov 20, 2026Market cap $233.65MP/E –Yield –

Amarin gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Amarin's gross profit for the twelve months ending Sep 30, 2026 was $72.11M, down 18.2% year over year. For fiscal 2025 it was $120.87M, up 48.5% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $482.62M in fiscal 2020.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$120.87M+48.5%
FY2024Dec 31, 2024$81.38M-50.8%
FY2023Dec 31, 2023$165.54M-31.7%
FY2022Dec 31, 2022$242.48M-47.5%
FY2021Dec 31, 2021$461.86M-4.3%
FY2020Dec 31, 2020$482.62M+44.6%
FY2019Dec 31, 2019$333.74M+91.1%
FY2018Dec 31, 2018$174.67M+28.3%
FY2017Dec 31, 2017$136.15M+42.2%
FY2016Dec 31, 2016$95.72M+77.7%
FY2015Dec 31, 2015$53.88M+59.8%
FY2014Dec 31, 2014$33.72M+133.5%
FY2013Dec 31, 2013$14.44M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$16.18M-27.1%
Q2 FY2026Jun 30, 2026$14.99M-70.2%
Q1 FY2026Mar 31, 2026$17.77M-29.3%
Q4 FY2025Dec 31, 2025$23.17M–
Q3 FY2025Sep 30, 2025$22.21M+36.4%
Q2 FY2025Jun 30, 2025$50.36M+17.8%
Q1 FY2025Mar 31, 2025$25.13M-21.2%
Q4 FY2024Dec 31, 2024-$9.57M-121.2%
Q3 FY2024Sep 30, 2024$16.28M-45.4%
Q2 FY2024Jun 30, 2024$42.77M+0.2%
Q1 FY2024Mar 31, 2024$31.90M-33.4%
Q4 FY2023Dec 31, 2023$45.12M-29.1%
Q3 FY2023Sep 30, 2023$29.82M-52.6%
Q2 FY2023Jun 30, 2023$42.67M-2.2%
Q1 FY2023Mar 31, 2023$47.93M-33.8%
Q4 FY2022Dec 31, 2022$63.60M-44.1%
Q3 FY2022Sep 30, 2022$62.86M-43.8%
Q2 FY2022Jun 30, 2022$43.63M-64.3%
Q1 FY2022Mar 31, 2022$72.39M-36.4%
Q4 FY2021Dec 31, 2021$113.86M-14.1%
Q3 FY2021Sep 30, 2021$111.83M-9.4%
Q2 FY2021Jun 30, 2021$122.33M+14.8%
Q1 FY2021Mar 31, 2021$113.84M-5.3%
Q4 FY2020Dec 31, 2020$132.48M+17.6%
Q3 FY2020Sep 30, 2020$123.43M+41.9%
Q2 FY2020Jun 30, 2020$106.52M+36.5%
Q1 FY2020Mar 31, 2020$120.19M+114.1%
Q4 FY2019Dec 31, 2019$112.61M+88.2%
Q3 FY2019Sep 30, 2019$86.96M+108.1%
Q2 FY2019Jun 30, 2019$78.02M+96.0%
Q1 FY2019Mar 31, 2019$56.14M+68.7%
Q4 FY2018Dec 31, 2018$59.82M+47.9%
Q3 FY2018Sep 30, 2018$41.78M+17.9%
Q2 FY2018Jun 30, 2018$39.80M+17.6%
Q1 FY2018Mar 31, 2018$33.27M+25.8%
Q4 FY2017Dec 31, 2017$40.43M+41.7%
Q3 FY2017Sep 30, 2017$35.44M–
Q2 FY2017Jun 30, 2017$33.84M–
Q1 FY2017Mar 31, 2017$26.44M–
Q4 FY2016Dec 31, 2016$28.54M–

More Amarin figures

See a number that looks wrong?